P53 mutations cooperate with oncogenic Kras to promote adenocarcinoma from pancreatic ductal cells

Oncogene

Volumn 35, Issue 32, 2016, Pages 4282-4288

  Bailey, J M ^a   Hendley, A M ^a   Lafaro, K J ^b   Pruski, M A ^a   Jones, N C ^a   Alsina, J ^c   Younes, M ^a   Maitra, A ^d   McAllister, F ^d   Iacobuzio Donahue, C A ^b   Leach, S D ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CERULETIDE; CYTOKERATIN 19; HEPATOCYTE NUCLEAR FACTOR 1BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KI 67 ANTIGEN; PROTEIN P53; STAT3 PROTEIN; TAMOXIFEN; KRAS PROTEIN, HUMAN; PHOSPHOPROTEIN; PROTEIN P21;

ACINAR CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL DEATH; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE ACTIVATION; GENE MUTATION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SPACE; MOUSE; NONHUMAN; ONCOGENE K RAS; PANCREAS ADENOCARCINOMA; PANCREAS CELL; PANCREATITIS; PRIORITY JOURNAL; SENESCENCE; SURVIVAL RATE; SURVIVAL TIME; ADENOCARCINOMA; ANIMAL; CELL AGING; GENETICS; HUMAN; METABOLISM; MUTATION; PANCREAS TUMOR; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ADENOCARCINOMA; ANIMALS; CARCINOGENESIS; CELL AGING; CELL LINE, TUMOR; HUMANS; MICE; MUTATION; PANCREATIC NEOPLASMS; PHOSPHOPROTEINS; PROTO-ONCOGENE PROTEINS P21(RAS); SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84982182050     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2015.441     Document Type: Article

References (18)

1. Waddell N, Pajic M, Patch AM, Chang DK, Kassahn KS, Bailey P et al. Whole genomes redefine the mutational landscape of pancreatic cancer. Nature 2015; 518: 495-501.
2. Kopp JL, von Figura G, Mayes E, Liu FF, Dubois CL, JPt Morris et al. Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma. Cancer Cell 2012; 22: 737-750.
3. Habbe N, Shi G, Meguid RA, Fendrich V, Esni F, Chen H et al. Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice. Proc Natl Acad Sci USA 2008; 105: 18913-18918.
4. Ji B, Tsou L, Wang H, Gaiser S, Chang DZ, Daniluk J et al. Ras activity levels control the development of pancreatic diseases. Gastroenterology 2009; 137: 82 e1-82 e6.
5. von Figura G, Fukuda A, Roy N, Liku ME, Morris IvJP, Kim GE et al. The chromatin regulator Brg1 suppresses formation of intraductal papillary mucinous neoplasm and pancreatic ductal adenocarcinoma. Nat Cell Biol 2014; 16: 255-267.
6. Guerra C, Schuhmacher AJ, Canamero M, Grippo PJ, Verdaguer L, Perez-Gallego L et al. Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. Cancer Cell 2007; 11: 291-302.
7. Bailey JM, Alsina J, Rasheed ZA, McAllister FM, Fu YY, Plentz R et al. DCLK1 marks a morphologically distinct subpopulation of cells with stem cell properties in preinvasive pancreatic cancer. Gastroenterology 2014; 146: 245-256.
8. Solar M, Cardalda C, Houbracken I, Martin M, Maestro MA, De Medts N et al. Pancreatic exocrine duct cells give rise to insulin-producing beta cells during embryogenesis but not after birth. Dev Cell 2009; 17: 849-860.
9. Strobel O, Dor Y, Alsina J, Stirman A, Lauwers G, Trainor A et al. In vivo lineage tracing defines the role of acinar-to-ductal transdifferentiation in inflammatory ductal metaplasia. Gastroenterology 2007; 133: 1999-2009.
10. Collisson EA, Trejo CL, Silva JM, Gu S, Korkola JE, Heiser LM et al. A central role for RAF-4MEK-4ERK signaling in the genesis of pancreatic ductal adenocarcinoma. Cancer Discov 2012; 2: 685-693.
11. Huang H, Daniluk J, Liu Y, Chu J, Li Z, Ji B et al. Oncogenic K-Ras requires activation for enhanced activity. Oncogene 2014; 33: 532-535.
12. Logsdon CD, Ji B. Ras activity in acinar cells links chronic pancreatitis and pancreatic cancer. Clin Gastroenterol 2009; 7(11 Suppl): S40-S43.
13. Morton JP, Timpson P, Karim SA, Ridgway RA, Athineos D, Doyle B et al. Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer. Proc Natl Acad Sci USA 2010; 107: 246-251.
14. Cooks T, Pateras IS, Tarcic O, Solomon H, Schetter AJ, Wilder S et al. Mutant p53 prolongs NF-kappaB activation and promotes chronic inflammation and inflammation-associated colorectal cancer. Cancer Cell 2013; 23: 634-646.
15. Coqueret O, Gascan H. Functional interaction of STAT3 transcription factor with the cell cycle inhibitor p21WAF1/CIP1/SDI1. J Biol Chem 2000; 275: 18794-18800.
16. Weissmueller S, Manchado E, Saborowski M, JPt Morris, Wagenblast E, Davis CA et al. Mutant p53 drives pancreatic cancer metastasis through cell-autonomous PDGF receptor beta signaling. Cell 2014; 157: 382-394.
17. Bailey JM, Alsina J, Rasheed ZA, McAllister FM, Fu YY, Plentz R et al. DCLK1 marks a morphologically distinct subpopulation of cells with stem cell properties in preinvasive pancreatic cancer. Gastroenterology 146: 245-256.
18. Siveke JT, Lubeseder-Martellato C, Lee M, Mazur PK, Nakhai H, Radtke F et al. Notch signaling is required for exocrine regeneration after acute pancreatitis. Gastroenterology 2008; 134: 544-555.